Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis.

Ruhland MK, Loza AJ, Capietto AH, Luo X, Knolhoff BL, Flanagan KC, Belt BA, Alspach E, Leahy K, Luo J, Schaffer A, Edwards JR, Longmore G, Faccio R, DeNardo DG, Stewart SA. · 2016

Read Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. by Ruhland MK, Loza AJ, Capietto AH, Luo X, Knolhoff BL, Flanagan KC, Belt BA, Alspach E, Leahy K, Luo J, Schaffer A, Edwards JR, Longmore G, Faccio R, DeNardo DG, Stewart SA. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4899869.txt.

Introduction

Megan K. Ruhland and co-authors showed in Nature Communications in 2016 that aged support cells in tissue can drive tumor growth by muting immunity. Age is a top cancer risk factor, but the steps were murky. A mouse model that copies aged skin showed senescent stromal cells, the tissue's support cells, suffice to raise local tumor promotion.

The aged cells drew in suppressive myeloid immune cells, which damped anti-tumor defense. One signal from the aged cells, interleukin-6, ran the recruitment. Clearing or quieting senescent support cells could thus cut age-linked cancer risk. The work ties a basic aging trait, worn-out cells, to a concrete cancer pathway.

Catalog record

CREATORRuhland MK, Loza AJ, Capietto AH, Luo X, Knolhoff BL, Flanagan KC, Belt BA, Alspach E, Leahy K, Luo J, Schaffer A, Edwards JR, Longmore G, Faccio R, DeNardo DG, Stewart SA.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE95 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4899869

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis By Megan K Ruhland, Andrew J Loza, Aude-Helene Capietto, Xianmin Luo, Brett L Knolhoff, Kevin C Flanagan, Brian A Belt, Elise Alspach, Kathleen Leahy, Jingqin Luo, Andras Schaffer, John R Edwards Published in: Nature Communications DOI: 10.1038/ncomms11762 ABSTRACT Abstract Age is a significant risk factor for the development of cancer. However, the mechanisms that drive age-related increases in cancer remain poorly understood. To determine if senescent stromal cells influence tumorigenesis, we develop a mouse model that mimics the aged skin microenvironment. Using this model, here we find that senescent stromal cells are sufficient to drive localized increases in suppressive myeloid cells that contributed to tumour promotion. Further, we find that the stromal-derived senescence-associated secretory phenotype factor interleukin-6 orchestrates both increases in suppressive myeloid cells and their ability to inhibit anti-tumour T-cell responses. Significantly, in aged, cancer-free individuals, we find similar increases in immune cells that also localize near senescent stromal cells. This work provides evidence that the accumulation of senescent stromal cells is sufficient to establish a tumour-permissive, chronic inflammatory microenvironment that can shelter incipient tumour cells, thus allowing them to proliferate and progress unabated by the immune system. Age significantly affects an individual's risk for developing cancer1. The factors that contribute to age-related increases in cancer are thought to include accumulation of stochastic mutations within incipient tumour cells and collaborative stromal changes that together drive tumorigenesis. While a plethora of cell-autonomous mutations have been shown to contribute to cellular transformation, how an aging stromal compartment develops and supports tumour outgrowth remains poorly understood. Inflammation may provide a link that explains how changes in the stromal compartment contribute to age-related increases in tumour development. Indeed, older individuals experience systemic changes in mediators of chronic inflammation including increases in cytokines and various immune cells such as immunosuppressive myeloid cells2,3,4,5,6. It remains unclear what drives these increases, but one contributing factor may be the accumulation of senescent cells that is known to occur with age7,8,9. Supporting the putative role of senescent cells in age-related increases in tumorigenesis is recent work showing that depletion of senescent cells in mice leads to a significant reduction in tumorigenesis10. However, the mechanisms that underlie this reduction remain to be addressed. Senescent cells are metabolically active cells that are characterized by an irreversible growth arrest. In addition, senescent cells express the cell cycle inhibitor p16INK4A (p16), senescence-associated β-galatosidase (SA-βgal), and an altered expression profile known as the senescence-associated secretory phenotype (SASP)11. Among the SASP cytokines, interleukin-6 (IL-6) is considered a canonical inflammatory factor12. IL-6 is elevated with age and coincides with increases in both circulating immunosuppressive myeloid cells and cancer incidence2,6. The possibility that stromal-derived SASP factors, including IL-6, mediate the establishment of chronic inflammation that predisposes a tissue to tumour outgrowth is intriguing. Senescence plays a paradoxical role in tumorigenesis, being both tumour-promoting and tumour-suppressive depending on the cell in which senescence occurs. Indeed, in some tumour models, senescent neoplastic cells can stimulate immune-mediated tumour cell clearance and thus, in this context, senescence functions as a potent tumour-suppressive mechanism13. However, in immune-compromised settings, when admixed with tumour cells, senescent stromal cells actively promote tumour growth through paracrine mechanisms14,15,16,17,18,19. These findings raise two important questions in the setting of an active immune system; (1) how do incipient tumour cells that arise within a senescent stromal compartment evade immune clearance and (2) can senescence within the stromal compartment affect the host immune response and adopt a pro-tumorigenic role? To address these important questions, we created an immune-competent mouse model to interrogate the role senescent stromal cells play in the preneoplastic, inflammatory microenvironment. Upon inducing senescence in the mesenchymal compartment, we find that in the absence of existing tumour cells, senescent stromal cells are sufficient to create an immunosuppressed environment, reminiscent of what we find in aging human skin. Further, we find that senescence-established immunosuppression facilitated tumour outgrowth by increasing myeloid-derived suppressor cells (MDSCs) capable of inhibiting CD8+ T-cell function. Together, these findings suggest a mechanism whereby senescent stromal cells contribute to age-related increases in tumorigenesis through the creation of local regions of immunosuppression. RESULTS Senescent stromal cells drive increased inflammation To determine if stromal-derived SASP affects the immune microenvironment, we developed a genetically engineered mouse to spatially and temporally control senescence activation exclusively in the stromal compartment20. Mice bearing a stromal-specific, tamoxifen (TAM)-inducible Cre-recombinase under the control of the pro-alpha 2(I)collagen promoter21 were mated to mice that conditionally activate expression of the cell cycle inhibitor p27Kip1 from the ROSA26 locus (ROSAlox-stop-lox-p27Kip1IRESGFP) (refs 21, 22). The p27Kip1 allele was used because it robustly activates senescence and SASP expression reminiscent of cells induced to senescence through telomere dysfunction, DNA damage-induced senescence and oncogene-induced senescence23. To first verify the relevance of p27Kip1 in age-related senescence, we stained human skin samples and found age-dependent increases in stromal p27Kip1 expression (Supplementary Fig. 1a,b). Thus p27Kip1 is a valid model for interrogating senescence-associated phenotypes. To establish the affect of stromal senescence on tumorigenesis, we first characterized our mouse model, termed the FASST mouse (fibroblasts accelerate stromal supported tumorigenesis), which upon TAM administration activates the p27Kip1 allele within cells of mesenchymal origin. Tissue samples were obtained from 6-week-old FASST and littermate control mice 2 weeks after transgene activation with TAM. To identify senescent cells, skin sections were stained for the senescence marker, senescence-associated β-galactosidase (SA-βgal) (Fig. 1a)7. We observed a significant increase in the number of senescent cells within the skin stroma of FASST mice compared with littermate controls (Fig. 1a,b) as well as within the mammary gland, lung (data not shown) and bone20, reflecting the mesenchymal nature of the collagen promoter used in our system. Importantly, this finding mimicked the mosaic pattern of senescent cell accumulation observed in aged human tissues7. [Figure: Senescent stromal cells induce local inflammation.(a) Senescence activation in FASST or littermate mice. Senescence-associated β-galactosidase (SA-βgal) staining (blue) of skin (arrows). Scale bar, 100 or 10 μm in zoomed images. * site of zoomed image. Representative images. (b) Quantification of SA-βgal+ cells per × 20 field of view (FOV). *P-value<0.05 by Student's t-test. Error bars represent s.e.m. Representative experiment. n=10. (c) RNA-seq shows expression of multiple cytokines and chemokines significantly increased in senescent MSFs (FDR<0.05, edgeR). Graph is log fold change (logFC) expression in Sen compared with Non-Sen MSFs. n=3. (d) CD45 IHC staining of skin from FASST or littermate mice. Arrows indicate CD45+ cells. Scale bar, 100 μm. Representative images. (e) Quantification of CD45+ cells per × 20 FOV. *P value<0.05 by Student's t-test. Error bars represent s.e.m. Representative experiment. n=9. (f) Schematic of transgenic expression cassette (top). Below, IF co-staining for transgenic GFP expression (green) and CD45+ cells (red). Nuclei stained with DAPI (blue). Scale bar, 100 or 10 μm in zoomed image. * site of zoomed images (right). Representative image. (g) Spatial analysis of CD45+ leukocytes and GFP+ stromal cells. Data show median distance between CD45+ leukocytes and GFP+ stromal cells (green) is significantly smaller than chance (mean normalized association score 3.5, 95% confidence interval (CI) 2.4–4.6). In the absence of senescent cells (littermate control), the observed distance distribution of immune cells to the epithelial layer (orange) is not significantly different from random (Epithelium-CD45) (mean normalized association score=1.0, 95% CI

Read the complete text